drugset / Trial / NCT01160341

Metabolic Syndrome Criteria and the Effect of Testosterone Treatment in Young Men With Hypogonadism

NCT01160341

Phase 4 Completed 312 enrolled Gulhane School of Medicine
NaSingle-groupOpen-labelScreening

Summary

The study is designed to answer the following questions: 1. Is hypogonadism a cause for the metabolic syndrome ? 2. What is the effect of testosterone replacement on the metabolic parameters ?

Timeline

Start
2009-08
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 250 mg Other

Indications